Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
Clinical trial NCT00193128 · COMPLETED
Trial details
- NCT number
- NCT00193128
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2008-02-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.